TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and namely to ophthalmology and can be used for treatment of wet form of age-related macular degeneration. Partial vitrectomy of pre-macular part of vitreous body is performed, and detachment of the back hyaloid membrane is induced without r...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | USUBOV EHMIN LOGMAN-OGLY BIKBOV MUKHARRAM MUKHTARAMOVICH SURKOVA VALENTINA KONSTANTINOVNA ALTYNBAEV URAL RIFOVICH |
| description | FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and namely to ophthalmology and can be used for treatment of wet form of age-related macular degeneration. Partial vitrectomy of pre-macular part of vitreous body is performed, and detachment of the back hyaloid membrane is induced without removing it. Avastin in quantity of 1.25 mg is injected to the formed retrohyaloid space. ^ EFFECT: method provides decrease of vitreoretinal traction in macular zone, increase of the preparation concentration above the injured section of amphiblestrodes - macular zone, and decrease of resorption speed of the preparation from vitreal cavity. ^ 3 dwg, 1 ex
Изобретение относится к медицине, а именно к офтальмологии, и может быть использовано для лечения влажной формы возрастной макулярной дегенерации. Выполняют частичную витрэктомию премакулярного отдела стекловидного тела, индуцируют отслойку задней гиалоидной мембраны без ее удаления. В сформировавшееся ретрогиалоидное пространство вводят препарат Авастин в дозе 1,25 мг. Способ обеспечивает снижение витреоретинальной тракции в макулярной зоне, повышение концентрации препарата над пораженным участком сетчатки - макулярной зоной, снижение скорости резорбции препарата из витреальной полости. 3 ил. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2368359C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2368359C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2368359C13</originalsourceid><addsrcrecordid>eNrjZDAJCXJ1DPF19QtR8HUN8fB3UfB3U3B0d9UNcvVxDHF1UfB1dA71cQxScHF1d_VzDXIM8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRsZmFsamls6GxkQoAQBxuScS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION</title><source>esp@cenet</source><creator>USUBOV EHMIN LOGMAN-OGLY ; BIKBOV MUKHARRAM MUKHTARAMOVICH ; SURKOVA VALENTINA KONSTANTINOVNA ; ALTYNBAEV URAL RIFOVICH</creator><creatorcontrib>USUBOV EHMIN LOGMAN-OGLY ; BIKBOV MUKHARRAM MUKHTARAMOVICH ; SURKOVA VALENTINA KONSTANTINOVNA ; ALTYNBAEV URAL RIFOVICH</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and namely to ophthalmology and can be used for treatment of wet form of age-related macular degeneration. Partial vitrectomy of pre-macular part of vitreous body is performed, and detachment of the back hyaloid membrane is induced without removing it. Avastin in quantity of 1.25 mg is injected to the formed retrohyaloid space. ^ EFFECT: method provides decrease of vitreoretinal traction in macular zone, increase of the preparation concentration above the injured section of amphiblestrodes - macular zone, and decrease of resorption speed of the preparation from vitreal cavity. ^ 3 dwg, 1 ex
Изобретение относится к медицине, а именно к офтальмологии, и может быть использовано для лечения влажной формы возрастной макулярной дегенерации. Выполняют частичную витрэктомию премакулярного отдела стекловидного тела, индуцируют отслойку задней гиалоидной мембраны без ее удаления. В сформировавшееся ретрогиалоидное пространство вводят препарат Авастин в дозе 1,25 мг. Способ обеспечивает снижение витреоретинальной тракции в макулярной зоне, повышение концентрации препарата над пораженным участком сетчатки - макулярной зоной, снижение скорости резорбции препарата из витреальной полости. 3 ил.</description><language>eng ; rus</language><subject>BANDAGES, DRESSINGS OR ABSORBENT PADS ; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS ; FILTERS IMPLANTABLE INTO BLOOD VESSELS ; FIRST-AID KITS ; FOMENTATION ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES ; PROSTHESES ; TREATMENT OR PROTECTION OF EYES OR EARS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090927&DB=EPODOC&CC=RU&NR=2368359C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090927&DB=EPODOC&CC=RU&NR=2368359C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>USUBOV EHMIN LOGMAN-OGLY</creatorcontrib><creatorcontrib>BIKBOV MUKHARRAM MUKHTARAMOVICH</creatorcontrib><creatorcontrib>SURKOVA VALENTINA KONSTANTINOVNA</creatorcontrib><creatorcontrib>ALTYNBAEV URAL RIFOVICH</creatorcontrib><title>TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION</title><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and namely to ophthalmology and can be used for treatment of wet form of age-related macular degeneration. Partial vitrectomy of pre-macular part of vitreous body is performed, and detachment of the back hyaloid membrane is induced without removing it. Avastin in quantity of 1.25 mg is injected to the formed retrohyaloid space. ^ EFFECT: method provides decrease of vitreoretinal traction in macular zone, increase of the preparation concentration above the injured section of amphiblestrodes - macular zone, and decrease of resorption speed of the preparation from vitreal cavity. ^ 3 dwg, 1 ex
Изобретение относится к медицине, а именно к офтальмологии, и может быть использовано для лечения влажной формы возрастной макулярной дегенерации. Выполняют частичную витрэктомию премакулярного отдела стекловидного тела, индуцируют отслойку задней гиалоидной мембраны без ее удаления. В сформировавшееся ретрогиалоидное пространство вводят препарат Авастин в дозе 1,25 мг. Способ обеспечивает снижение витреоретинальной тракции в макулярной зоне, повышение концентрации препарата над пораженным участком сетчатки - макулярной зоной, снижение скорости резорбции препарата из витреальной полости. 3 ил.</description><subject>BANDAGES, DRESSINGS OR ABSORBENT PADS</subject><subject>DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS</subject><subject>FILTERS IMPLANTABLE INTO BLOOD VESSELS</subject><subject>FIRST-AID KITS</subject><subject>FOMENTATION</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES</subject><subject>PROSTHESES</subject><subject>TREATMENT OR PROTECTION OF EYES OR EARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJCXJ1DPF19QtR8HUN8fB3UfB3U3B0d9UNcvVxDHF1UfB1dA71cQxScHF1d_VzDXIM8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRsZmFsamls6GxkQoAQBxuScS</recordid><startdate>20090927</startdate><enddate>20090927</enddate><creator>USUBOV EHMIN LOGMAN-OGLY</creator><creator>BIKBOV MUKHARRAM MUKHTARAMOVICH</creator><creator>SURKOVA VALENTINA KONSTANTINOVNA</creator><creator>ALTYNBAEV URAL RIFOVICH</creator><scope>EVB</scope></search><sort><creationdate>20090927</creationdate><title>TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION</title><author>USUBOV EHMIN LOGMAN-OGLY ; BIKBOV MUKHARRAM MUKHTARAMOVICH ; SURKOVA VALENTINA KONSTANTINOVNA ; ALTYNBAEV URAL RIFOVICH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2368359C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2009</creationdate><topic>BANDAGES, DRESSINGS OR ABSORBENT PADS</topic><topic>DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS</topic><topic>FILTERS IMPLANTABLE INTO BLOOD VESSELS</topic><topic>FIRST-AID KITS</topic><topic>FOMENTATION</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES</topic><topic>PROSTHESES</topic><topic>TREATMENT OR PROTECTION OF EYES OR EARS</topic><toplevel>online_resources</toplevel><creatorcontrib>USUBOV EHMIN LOGMAN-OGLY</creatorcontrib><creatorcontrib>BIKBOV MUKHARRAM MUKHTARAMOVICH</creatorcontrib><creatorcontrib>SURKOVA VALENTINA KONSTANTINOVNA</creatorcontrib><creatorcontrib>ALTYNBAEV URAL RIFOVICH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>USUBOV EHMIN LOGMAN-OGLY</au><au>BIKBOV MUKHARRAM MUKHTARAMOVICH</au><au>SURKOVA VALENTINA KONSTANTINOVNA</au><au>ALTYNBAEV URAL RIFOVICH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION</title><date>2009-09-27</date><risdate>2009</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and namely to ophthalmology and can be used for treatment of wet form of age-related macular degeneration. Partial vitrectomy of pre-macular part of vitreous body is performed, and detachment of the back hyaloid membrane is induced without removing it. Avastin in quantity of 1.25 mg is injected to the formed retrohyaloid space. ^ EFFECT: method provides decrease of vitreoretinal traction in macular zone, increase of the preparation concentration above the injured section of amphiblestrodes - macular zone, and decrease of resorption speed of the preparation from vitreal cavity. ^ 3 dwg, 1 ex
Изобретение относится к медицине, а именно к офтальмологии, и может быть использовано для лечения влажной формы возрастной макулярной дегенерации. Выполняют частичную витрэктомию премакулярного отдела стекловидного тела, индуцируют отслойку задней гиалоидной мембраны без ее удаления. В сформировавшееся ретрогиалоидное пространство вводят препарат Авастин в дозе 1,25 мг. Способ обеспечивает снижение витреоретинальной тракции в макулярной зоне, повышение концентрации препарата над пораженным участком сетчатки - макулярной зоной, снижение скорости резорбции препарата из витреальной полости. 3 ил.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2368359C1 |
| source | esp@cenet |
| subjects | BANDAGES, DRESSINGS OR ABSORBENT PADS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PROSTHESES TREATMENT OR PROTECTION OF EYES OR EARS |
| title | TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A46%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=USUBOV%20EHMIN%20LOGMAN-OGLY&rft.date=2009-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2368359C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |